Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML

Blood (2023) 141 (3): 295–308.

https://doi.org/10.1182/blood.2022016916

Published: 2023

Includes: Supplemental data

Journal Articles

Novel Data Analytics Identify Predictors of Quality-of-Life Trajectories in Patients with AML or High-Risk Myeloid Neoplasms

Blood (2022) 140 (Supplement 1): 5254–5257.

https://doi.org/10.1182/blood-2022-165437

Published: 2022

Journal Articles

Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia

Blood (2021) 138 (5): 387–400.

https://doi.org/10.1182/blood.2020008812

Published: 2021

Includes: Supplemental data

Journal Articles

Limitations to Receiving Allogeneic Hematopoietic Cell Transplantation for Treatment of Acute Myeloid Leukemia: A Large Multi-Center Prospective Longitudinal Observational Study

Blood (2018) 132 (Supplement 1): 1388.

https://doi.org/10.1182/blood-2018-99-112672

Published: 2018

Journal Articles

Survival Differences Among Patients (pts) with Acute Myeloid Leukemia (AML) Treated with Allogeneic Hematopoietic Cell Transplantation (HCT) Versus Non-HCT Therapies: A Large Real-Time Multi-Center Prospective Longitudinal Observational Study

Blood (2018) 132 (Supplement 1): 207.

https://doi.org/10.1182/blood-2018-99-113094

Published: 2018

Journal Articles

Fludarabine, Cyclophosphamide, Rituximab (FCR) and Vorinostat Followed By Rituximab and Vorinostat Maintenance Therapy in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL) - Final Results of a Phase I/II Study

Mazyar Shadman, MD MPH, Ajay K Gopal, MD, Oliver Press, MD PhD, David G. Maloney, MD PhD, Raya Mawad, MD, Troy Wadsworth, MD, Trevor W. Dennie, MD, Karl Schultheiss, MD, Kiarash Kojouri, MD MPH, Britt E Kammerer, John M. Pagel, MD PhD

Blood (2016) 128 (22): 4396.

https://doi.org/10.1182/blood.V128.22.4396.4396

Published: 2016

Journal Articles

A Phase I/II Study Of Fludarabine, Cyclophosphamide, Rituximab and Vorinostat Followed By Rituximab and Vorinostat Maintenance Therapy In Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia (CLL) Or Small Lymphocytic Leukemia (SLL)

Raya Mawad, MD, Ajay K. Gopal, MD, Oliver W. Press, MD, PhD, David G. Maloney, MD, PhD, Stephen H. Petersdorf, MD, Troy Wadsworth, MD, Trevor W. Dennie, MD, Yoshio Inoue, MD, Karl J. Schultheiss, MD, Kiarash Kojouri, MD, MPH, Kelly M. Smith, MD, Britt Kammerer, John M. Pagel, MD, PhD

Blood (2013) 122 (21): 4191.

https://doi.org/10.1182/blood.V122.21.4191.4191

Published: 2013

Journal Articles

Full Dose Bendamustine (Treanda ®) Can Be Safely Combined with Rituximab, Etoposide and Carboplatin (TREC): Results of a Phase I Trial in Patients with Relapsed or Refractory Lymphoma

Lihua Elizabeth Budde, MD, PhD, Shustov R Andrei, M.D., Gooley Ted, Ph.D., Tara L Chen, PharmD, BCOP, Edward N. Libby, III, MD, Maria Corinna Palanca-Wessels, M.D., Ph.D., Mary Philip, MD, PhD, Daniel B. Martin, M.D., Ryan D. Cassaday, MD, Kiarash Kojouri, MD, MPH, Oliver W. Press, MD, PhD, Ajay K. Gopal, MD

Blood (2012) 120 (21): 3650.

https://doi.org/10.1182/blood.V120.21.3650.3650

Published: 2012

Journal Articles

A 4-Drug, Weekly Combination Regimen of Bortezomib, Cyclophosphamide, Liposomal Doxorubicin, and Dexamethasone for Initial Treatment of Multiple Myeloma

Pamela S. Becker, MD, PhD, Ted A. Gooley, PhD, Kathy Lilleby, RN, Damian J. Green, MD, Nicholas Burwick, MD, Christine Wallace, Theodore Kim, DO, Kiarash Kojouri, MD, MPH, Erin Nelli, DO, William I. Bensinger, MD

Blood (2012) 120 (21): 5038.

https://doi.org/10.1182/blood.V120.21.5038.5038

Published: 2012

Journal Articles

Prognostic Significance of BCL-2 Expression in Patients with Multiple Myeloma.

Mehmood Hashmi, M.D., Kiarash Kojouri, M.D., Jian Yang, M.D., Sunil Patel, M.D., Mohammad Khan, M.D., Nancy Sylvester-Kohrt, R.N., Rammurti Kamble, M.D., George B. Selby, M.D., Howard Ozer, M.D., Mohamed A. Kharfan-Dabaja, M.D.

Blood (2004) 104 (11): 4840.

https://doi.org/10.1182/blood.V104.11.4840.4840

Published: 2004

Journal Articles

Prognostic Significance of Hypoalbuminemia in Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Salvage Autologous Bone Marrow/Peripheral Stem Cell Transplantation (auto-BM/PSCT).

Kiarash Kojouri, MD, MPH, Christian El-Khoury, MD, Shubham Pant, MD, Nancy Kohrt, RN, George B. Selby, MD, Howard Ozer, MD, PhD, Rammurti Kamble, MD, Mohamed A. Kharfan-Dabaja, MD

Blood (2004) 104 (11): 5204.

https://doi.org/10.1182/blood.V104.11.5204.5204

Published: 2004

Journal Articles

Evaluation of Body Mass Index (BMI) as a Prognostic Factor among Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Autologous Bone Marrow/Peripheral Stem Cell Transplantation (Auto-BM/PSCT).

Christian El-Khoury, MD, Kiarash Kojouri, MD, MPH, Shubham Pant, MD, Nancy Sylvester-Kohrt, RN, George B. Selby, MD, Howard Ozer, MD, PhD, Rammurti Kamble, MD, Mohamed A. Kharfan-Dabaja, MD

Blood (2004) 104 (11): 5206.

https://doi.org/10.1182/blood.V104.11.5206.5206

Published: 2004

Journal Articles

Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications

Kiarash Kojouri, Sara K. Vesely, Deirdra R. Terrell, James N. George

Blood (2004) 104 (9): 2623–2634.

https://doi.org/10.1182/blood-2004-03-1168

Published: 2004

NARROW

An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML

Novel Data Analytics Identify Predictors of Quality-of-Life Trajectories in Patients with AML or High-Risk Myeloid Neoplasms

Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia

Limitations to Receiving Allogeneic Hematopoietic Cell Transplantation for Treatment of Acute Myeloid Leukemia: A Large Multi-Center Prospective Longitudinal Observational Study

Survival Differences Among Patients (pts) with Acute Myeloid Leukemia (AML) Treated with Allogeneic Hematopoietic Cell Transplantation (HCT) Versus Non-HCT Therapies: A Large Real-Time Multi-Center Prospective Longitudinal Observational Study

Fludarabine, Cyclophosphamide, Rituximab (FCR) and Vorinostat Followed By Rituximab and Vorinostat Maintenance Therapy in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL) - Final Results of a Phase I/II Study

A Phase I/II Study Of Fludarabine, Cyclophosphamide, Rituximab and Vorinostat Followed By Rituximab and Vorinostat Maintenance Therapy In Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia (CLL) Or Small Lymphocytic Leukemia (SLL)

Full Dose Bendamustine (Treanda ®) Can Be Safely Combined with Rituximab, Etoposide and Carboplatin (TREC): Results of a Phase I Trial in Patients with Relapsed or Refractory Lymphoma

A 4-Drug, Weekly Combination Regimen of Bortezomib, Cyclophosphamide, Liposomal Doxorubicin, and Dexamethasone for Initial Treatment of Multiple Myeloma

Prognostic Significance of BCL-2 Expression in Patients with Multiple Myeloma.

Prognostic Significance of Hypoalbuminemia in Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Salvage Autologous Bone Marrow/Peripheral Stem Cell Transplantation (auto-BM/PSCT).

Evaluation of Body Mass Index (BMI) as a Prognostic Factor among Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Autologous Bone Marrow/Peripheral Stem Cell Transplantation (Auto-BM/PSCT).

Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only